Targeted Oncology

FDA Expands Approval of Aptima HPV Assay for Cervical Cancer Primary Screening

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
Rutland Herald

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...
CNN

HPV testing preferred over Pap for cervical cancer screening starting at age 30, task force’s draft recommendation says

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...
The Star

Expand HPV DNA testing to strengthen cervical cancer screening

EARLY detection through proper screening is key to eliminating cervical cancer, but awareness and access remain major hurdles in Malaysia. One challenge is the slow adoption of human papillomaviruses ...